Shivanshu Madan is a Cardiology physician. OpenAlex indexes 16 publications with 239 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2500 Rocky Mountain Ave Ste 100
Loveland, CO 805389004
Telephone
970-221-1000Provider last certified this registry record 18 Mar 2020.
Industry payments
14 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Medtronic, Inc.Program year20259 payments
- ABIOMEDProgram year20256 payments
- Abbott LaboratoriesProgram year20254 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
84.1%Statin22.4%Atorvastatin Calcium59%Rosuvastatin Calcium28%Pravastatin Sodium8%Simvastatin5%Part D≥152 patientsBeta blocker22%Carvedilol40%Metoprolol Succinate37%Metoprolol Tartrate21%Atenolol3%Part D<11 patients+ 15 more classes in this area
Blood & clotting
12.8%Factor Xa inhibitor6.4%Eliquis81%Xarelto20%Part D≥60 patientsP2Y12 inhibitor4.8%Clopidogrel100%Part D≥69 patients+ 2 more classes in this area
Metabolism & gastrointestinal
3.1%Potassium supplement2.1%Potassium Chloride100%Part D≥30 patientsSGLT2 inhibitor1%Jardiance100%Part D≥15 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Clinical Outcomes and Sustainability of Using <i>CYP2C19</i> Genotype–Guided Antiplatelet Therapy After Percutaneous Coronary Intervention
Circulation Genomic and Precision Medicine
2018 - Recurrent anaphylaxis during cardiac catheterization due to ethylene oxide
The Journal of Allergy and Clinical Immunology In Practice
2018 - A Multidisciplinary Continuous Support Heart Team Approach Improves Survival in Continuous Flow LVAD Recipients
The Journal of Heart and Lung Transplantation
2018 - THE INFLAMMATORY IMPOSTER: FOCAL MYOCARDITIS MASQUERADING AS ACUTE MYOCARDIAL INFARCTION
Journal of the American College of Cardiology
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”